While the intrinsic costimulatory signal of CD2 in T cells remains important, leveraging its interaction with CD58 on tumors appears to be a pivotal mechanism in the regulation of tumor immunity and requires novel strategies. The gene discussed is CD2; the disease is neoplasm.